Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BFB HealthHKSE:00205 36 ROE % is -4.37% as of Dec. 2025. GuruFocus rates HKSE:00205 with a GF Score™ of 36/100 and a GF Value™ of HK$0.14 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 948 Media - Diversified companies, BFB Health ranks worse than 64.77% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. BFB Health's annualized net income for the quarter that ended in Dec. 2025 was HK$-9.42 Mil. BFB Health's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was HK$215.56 Mil. Therefore, BFB Health's annualized ROE % for the quarter that ended in Dec. 2025 was -4.37%.
The historical rank and industry rank for BFB Health's ROE % or its related term are showing as below:
HKSE:00205'
s ROE % Range Over the Past 10 Years
Min: -41.06 Med: -19.63 Max: -1.62
Current: -2.74
During the past 13 years, BFB Health's highest ROE % was -1.62%. The lowest was -41.06%. And the median was -19.63%.
HKSE:00205's ROE % is ranked worse than 64.77% of 948
companies
in the Media - Diversified industry
Industry Median: 2.405
vs HKSE:00205: -2.74
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
BFB Health ROE % Related Terms
BFB Health ROE % Historical Data
* Premium members only.
The historical data trend for BFB Health's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Advertising Agencies subindustry, BFB Health's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BFB Health ROE % vs Media - Diversified Industry
For the Media - Diversified industry and Communication Services sector, BFB Health's ROE % distribution charts can be found below:
* The bar in red indicates where BFB Health's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
BFB Health (HKSE:00205) has a ROE % of -4.37% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on BFB Health and its competitors. According to the industry distribution chart, BFB Health ranks #614 out of 948 companies in the Media - Diversified industry, placing it in the top 64.8%.
Is BFB Health's ROE % too high?
BFB Health's current ROE % is -4.37%. Based on the distribution chart, BFB Health ranks #614 out of 948 companies in the Media - Diversified industry, which is below the industry midpoint. Overall, BFB Health has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does BFB Health's ROE % compare to APP and OMC?
According to the Media - Diversified industry distribution chart, BFB Health ranks #614 out of 948 companies for ROE %. This places BFB Health in the lower half of its industry. The industry median ROE % is 2.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Media - Diversified company?
The median ROE % among Media - Diversified companies is 2.41, based on 948 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on BFB Health and its competitors. For the Media - Diversified industry, the median ROE % is 2.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BFB Health's current ROE % is -4.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BFB Health stock overvalued right now?
Based on GuruFocus' analysis, BFB Health (HKSE:00205) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.14, compared to a current price of HK$0.55 — trading 292.9% above its estimated fair value. The current ROE % is -4.37%. BFB Health's overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For BFB Health (HKSE:00205), the current ROE % is -4.37% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BFB Health (HKSE:00205) Overvalued in 2026?
Based on GuruFocus' analysis, BFB Health stock appears to be overvalued.
The current stock price of HK$0.55 is trading 292.9% above its estimated GF Value™ of HK$0.14.
GuruFocus considers BFB Health to be Significantly Overvalued.
Key valuation signals for HKSE:00205:
ROE %: -4.37%
GF Value™: HK$0.14 vs. price of HK$0.55 (292.9% above fair value)
No single metric tells the full story. See the HKSE:00205 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BFB Health Ltd is an investment holding company. Along with its subsidiaries, it operates in the following reportable segments: Provision of advertising and e-commerce business, Provision of securities broking services, and Money lending. Maximum revenue is derived from the Provision of advertising and e-commerce business, which generates the majority of its revenue from the sales of health and wellness products, through e-commerce channels, and the rest comes from the provision of advertising services, sales of books and magazines, and multi-channel network activities. Geographically, the Group generates maximum revenue from the People's Republic of China (PRC), and the rest from Hong Kong.
36GF Score
Get the complete analysis for HKSE:00205
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00205 has been successfully added to your 
